← Back
$RCUS All transactions

Arcus Biosciences, Inc.

A

$ Value

$0

Shares

96,000

Price

$0

Filed

Jan 26

Insider

Name

Tang Carolyn C.

Title

General Counsel

CIK

0001836662

Roles

Officer

Transaction Details

Transaction Date

2026-01-23

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

96,000

Footnotes

Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company. | Includes the unvested portion of the Reporting Person's RSU grants. | The option becomes exercisable in 48 equal monthly installments after January 1, 2026, subject to the Reporting Person's continued service to the Company.

Filing Info

Accession No.

0001836662-26-000002

Form Type

4

Issuer CIK

0001724521

Tang Carolyn C.'s History

Date Ticker Type Value
2026-01-23 RCUS A $0
2026-01-23 RCUS A $0
2025-12-17 RCUS $151K
2025-12-16 RCUS $168K

Other Insiders at RCUS (90d)

Insider Bought Sold Last
ROSEN TERRY J
Chief Executive Officer
2026-01-23
Jaen Juan C.
President
2026-01-23
Goeltz II Robert C.
Chief Financial Officer
2026-01-23
Jarrett Jennifer
Chief Operating Officer
2026-01-23
Azoy Alexander
Chief Accounting Officer
2026-01-23
Tang Carolyn C.
General Counsel
2026-01-23
Markus Richard
Chief Medical Officer
2026-01-23